| M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination VE Miron, A Boyd, JW Zhao, TJ Yuen, JM Ruckh, JL Shadrach, ... Nature neuroscience 16 (9), 1211-1218, 2013 | 1716 | 2013 |
| Altered human oligodendrocyte heterogeneity in multiple sclerosis S Jäkel, E Agirre, A Mendanha Falcão, D Van Bruggen, KW Lee, ... Nature 566 (7745), 543-547, 2019 | 595 | 2019 |
| Retinoid X receptor gamma signaling accelerates CNS remyelination JK Huang, AA Jarjour, B Nait Oumesmar, C Kerninon, A Williams, ... Nature neuroscience 14 (1), 45-53, 2011 | 544 | 2011 |
| Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis AM Falcão, D van Bruggen, S Marques, M Meijer, S Jäkel, E Agirre, ... Nature medicine 24 (12), 1837-1844, 2018 | 395 | 2018 |
| Regulatory T cells promote myelin regeneration in the central nervous system Y Dombrowski, T O'hagan, M Dittmer, R Penalva, SR Mayoral, ... Nature neuroscience 20 (5), 674-680, 2017 | 391 | 2017 |
| Astrocytes—friends or foes in multiple sclerosis? A Williams, G Piaton, C Lubetzki Glia 55 (13), 1300-1312, 2007 | 352 | 2007 |
| Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open … R Kapoor, PR Ho, N Campbell, I Chang, A Deykin, F Forrestal, N Lucas, ... The Lancet Neurology 17 (5), 405-415, 2018 | 326 | 2018 |
| Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models A Boyd, H Zhang, A Williams Acta neuropathologica 125, 841-859, 2013 | 279 | 2013 |
| Remyelination in multiple sclerosis: from basic science to clinical translation C Lubetzki, B Zalc, A Williams, C Stadelmann, B Stankoff The Lancet Neurology 19 (8), 678-688, 2020 | 258 | 2020 |
| A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot–Marie–Tooth disease A Guilbot, A Williams, N Ravisé, C Verny, A Brice, DL Sherman, ... Human molecular genetics 10 (4), 415-422, 2001 | 257 | 2001 |
| Central nervous system regeneration is driven by microglia necroptosis and repopulation AF Lloyd, CL Davies, RK Holloway, Y Labrak, G Ireland, D Carradori, ... Nature neuroscience 22 (7), 1046-1052, 2019 | 253 | 2019 |
| Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? A Williams, G Piaton, MS Aigrot, A Belhadi, M Théaudin, F Petermann, ... Brain 130 (10), 2554-2565, 2007 | 251 | 2007 |
| Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl‐11C]‐2‐(4′‐methylaminophenyl)‐ 6 … B Stankoff, L Freeman, MS Aigrot, A Chardain, F Dollé, A Williams, ... Annals of neurology 69 (4), 673-680, 2011 | 219 | 2011 |
| Improving the translational hit of experimental treatments in multiple sclerosis HM Vesterinen, ES Sena, C Ffrench-Constant, A Williams, S Chandran, ... Multiple Sclerosis Journal 16 (9), 1044-1055, 2010 | 207 | 2010 |
| Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis AM Nicaise, LJ Wagstaff, CM Willis, C Paisie, H Chandok, P Robson, ... Proceedings of the National Academy of Sciences 116 (18), 9030-9039, 2019 | 175 | 2019 |
| Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system G Piaton, MS Aigrot, A Williams, S Moyon, V Tepavcevic, I Moutkine, ... Brain 134 (4), 1156-1167, 2011 | 175 | 2011 |
| Reversal of endothelial dysfunction reduces white matter vulnerability in cerebral small vessel disease in rats RM Rajani, S Quick, SR Ruigrok, D Graham, SE Harris, BFJ Verhaaren, ... Science translational medicine 10 (448), eaam9507, 2018 | 168 | 2018 |
| Central nervous system remyelination in culture—A tool for multiple sclerosis research H Zhang, AA Jarjour, A Boyd, A Williams Experimental neurology 230 (1), 138-148, 2011 | 151 | 2011 |
| Influence of intracerebral hemorrhage location on incidence, characteristics, and outcome: population-based study N Samarasekera, A Fonville, C Lerpiniere, AJ Farrall, JM Wardlaw, ... Stroke 46 (2), 361-368, 2015 | 147 | 2015 |
| Periaxin mutations cause a broad spectrum of demyelinating neuropathies H Takashima, CF Boerkoel, P De Jonghe, C Ceuterick, JJ Martin, T Voit, ... Annals of Neurology: Official Journal of the American Neurological …, 2002 | 127 | 2002 |
Veronique MironThe University of TorontoVerified email at unityhealth.to
